1. Home
  2. TFPM vs BLCO Comparison

TFPM vs BLCO Comparison

Compare TFPM & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TFPM

Triple Flag Precious Metals Corp.

HOLD

Current Price

$41.25

Market Cap

6.8B

Sector

Industrials

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$18.25

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFPM
BLCO
Founded
2016
1853
Country
Canada
Canada
Employees
N/A
N/A
Industry
Precious Metals
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
6.0B
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
TFPM
BLCO
Price
$41.25
$18.25
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$35.33
$18.55
AVG Volume (30 Days)
590.5K
411.5K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
0.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$17.71
$7.45
Revenue Next Year
N/A
$5.49
P/E Ratio
$35.57
N/A
Revenue Growth
N/A
6.47
52 Week Low
$16.54
$10.45
52 Week High
$40.50
$18.92

Technical Indicators

Market Signals
Indicator
TFPM
BLCO
Relative Strength Index (RSI) 66.94 63.34
Support Level $32.31 $16.35
Resistance Level N/A N/A
Average True Range (ATR) 1.30 0.60
MACD 0.53 0.13
Stochastic Oscillator 98.05 75.05

Price Performance

Historical Comparison
TFPM
BLCO

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: